Their findings demonstrated that triptolide prevented investigational dissemination of B16F10 cells to the spleen and lungs of mice and had anti-tumor efficacy against a wide range of cancers that include both wild type or mutant versions of p53 [22]. Here, TP53 is linked to neoplasm.